Joel V. Chua

Inclusion of information on risk factors, socio-economic status and health seeking in a tuberculosis prevalence survey.

Knut Lönnroth, Timothy H. Holtz, Frank Cobelens et al. · Data Archiving and Networked Services (DANS) · 2009 · 31 citations

Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosis

Varun Saxena, M. Michele Manos, Helen S. Yee et al. · Alimentary Pharmacology & Therapeutics · 2014 · 25 citations · Full text

A pilot study of safety and efficacy of HCV retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with or without HIV (RESOLVE STUDY)

Eleanor Wilson, Emily Covert, Jennifer Hoffmann et al. · Journal of Hepatology · 2019 · 24 citations · Full text

Resolve Study, Hcv Retreatment, Hiv/aids Counselling +10

RNA Interference Therapeutics for Chronic Hepatitis B: Progress, Challenges, and Future Prospects

Laura Sneller, Christine Y. Lin, Angie Price et al. · Microorganisms · 2024 · 24 citations · Full text

Future Prospects, Immunology, Hepatitis B +17

Neglected but not Forgotten: Current Trends and Limitations in Dengue Antiviral Research

O. Juliet, Hernando Gutiérrez-Barbosa, Joel V. Chua et al. · Preprints.org · 2021 · 20 citations · Full text

Immunology, Approved Vaccine, Molecular Biology +20